157 related articles for article (PubMed ID: 21146154)
21. Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.
Allen MR; Kubek DJ; Burr DB; Ruggiero SL; Chu TM
Osteoporos Int; 2011 Feb; 22(2):693-702. PubMed ID: 20458574
[TBL] [Abstract][Full Text] [Related]
22. Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid.
Steller D; Herbst N; Pries R; Juhl D; Hakim SG
Sci Rep; 2019 Jun; 9(1):8310. PubMed ID: 31165745
[TBL] [Abstract][Full Text] [Related]
23. Zoledronic acid suppresses transforming growth factor-β-induced fibrogenesis by human gingival fibroblasts.
Komatsu Y; Ibi M; Chosa N; Kyakumoto S; Kamo M; Shibata T; Sugiyama Y; Ishisaki A
Int J Mol Med; 2016 Jul; 38(1):139-47. PubMed ID: 27176567
[TBL] [Abstract][Full Text] [Related]
24. Response of a co-culture model of epithelial cells and gingival fibroblasts to zoledronic acid.
Basso FG; Soares DG; Pansani TN; Turrioni AP; Scheffel DL; Hebling J; Costa CA
Braz Oral Res; 2016 Nov; 30(1):e122. PubMed ID: 27901204
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase-9 expression in alveolar extraction sockets of Zoledronic acid-treated rats.
Basi DL; Hughes PJ; Thumbigere-Math V; Sabino M; Mariash A; Lunos SA; Jensen E; Gopalakrishnan R
J Oral Maxillofac Surg; 2011 Nov; 69(11):2698-707. PubMed ID: 21752506
[TBL] [Abstract][Full Text] [Related]
26. Prevention of tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaws with basic fibroblast growth factor: An experimental study in rats.
Imada M; Yagyuu T; Ueyama Y; Maeda M; Yamamoto K; Kurokawa S; Jo JI; Tabata Y; Tanaka Y; Kirita T
PLoS One; 2019; 14(2):e0211928. PubMed ID: 30735554
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of zoledronate and compressive force suppresses proliferation and differentiation of human gingival fibroblasts.
Hemmi T; Yusa K; Ishikawa S; Takano H; Fukuda M; Iino M
Br J Oral Maxillofac Surg; 2024 Jan; 62(1):63-70. PubMed ID: 38097403
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge.
Markiewicz MR; Margarone JE; Campbell JH; Aguirre A
J Am Dent Assoc; 2005 Dec; 136(12):1669-74. PubMed ID: 16383048
[TBL] [Abstract][Full Text] [Related]
29. A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw.
Mawardi H; Giro G; Kajiya M; Ohta K; Almazrooa S; Alshwaimi E; Woo SB; Nishimura I; Kawai T
J Dent Res; 2011 Nov; 90(11):1339-45. PubMed ID: 21921248
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts.
Basso FG; Pansani TN; de Oliveira CF; Turrioni AP; Soares DG; Hebling J; Costa CA
Braz Dent J; 2013; 24(6):551-8. PubMed ID: 24474348
[TBL] [Abstract][Full Text] [Related]
31. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate-induced reactive oxygen species inhibit proliferation and migration of oral fibroblasts: A pathogenesis of bisphosphonate-related osteonecrosis of the jaw.
Taniguchi N; Osaki M; Onuma K; Ishikawa M; Ryoke K; Kodani I; Okada F
J Periodontol; 2020 Jul; 91(7):947-955. PubMed ID: 31863459
[TBL] [Abstract][Full Text] [Related]
33. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
Brown JJ; Ramalingam L; Zacharin MR
Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397
[TBL] [Abstract][Full Text] [Related]
34. Effects of low-level laser therapy on the proliferation and apoptosis of gingival fibroblasts treated with zoledronic acid.
Pansani TN; Basso FG; Turirioni AP; Kurachi C; Hebling J; de Souza Costa CA
Int J Oral Maxillofac Surg; 2014 Aug; 43(8):1030-4. PubMed ID: 24656494
[TBL] [Abstract][Full Text] [Related]
35. Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention.
Gibbs SD; O'Grady J; Seymour JF; Prince HM
Med J Aust; 2005 Nov; 183(10):549-50. PubMed ID: 16296983
[No Abstract] [Full Text] [Related]
36. Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.
Ficarra G; Beninati F
Head Neck Pathol; 2007 Dec; 1(2):132-40. PubMed ID: 20614264
[TBL] [Abstract][Full Text] [Related]
37. The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.
Allen MR
Odontology; 2011 Jan; 99(1):8-17. PubMed ID: 21271320
[TBL] [Abstract][Full Text] [Related]
38. Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat model: A major adverse effect of bisphosphonate therapy.
Tamari T; Elimelech R; Cohen G; Cohen T; Doppelt O; Eskander-Hashoul L; Zigdon-Giladi H
Sci Rep; 2019 Dec; 9(1):18896. PubMed ID: 31827217
[TBL] [Abstract][Full Text] [Related]
39. The bisphosphonate zoledronic acid regulates key angiogenesis-related genes in primary human gingival fibroblasts.
Ohlrich EJ; Coates DE; Cullinan MP; Milne TJ; Zafar S; Zhao Y; Duncan WD; Seymour GJ
Arch Oral Biol; 2016 Mar; 63():7-14. PubMed ID: 26658366
[TBL] [Abstract][Full Text] [Related]
40. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?
Reid IR; Bolland MJ; Grey AB
Bone; 2007 Sep; 41(3):318-20. PubMed ID: 17572168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
